Halozyme Therapeutics, Inc. (BIT:1HALO)
Italy
· Delayed Price · Currency is EUR 46.22
0.00 (0.00%)
At close: Jun 4, 2025, 5:30 PM CET
Halozyme Therapeutics Market Cap
Halozyme Therapeutics has a market cap or net worth of €5.76 billion as of June 6, 2025. Its market cap has increased by 9.35% in one year.
Market Cap
5.76B
Enterprise Value
6.45B
Revenue
1.00B
Ranking
n/a
PE Ratio
12.83
Stock Price
€46.22
Market Cap Chart
Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 141.66M to 5.76B, an increase of 3,967.95%. That is a compound annual growth rate of 19.23%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UniCredit | 90.05B |
| Intesa Sanpaolo | 89.25B |
| Enel SpA | 81.37B |
| Ferrari | 75.20B |
| Assicurazioni Generali | 48.95B |
| Eni S.p.A. | 38.77B |
| Leonardo S.p.a. | 31.30B |
| Stellantis | 24.73B |